Look at this owl and its great camouflage resembling bark. A sequence with good LOD (good scope) would be the image on the left, while one with poor performance would be the image on the left. Maybe there is an owl but hard to tell! END https://t.co/rKZ
This paper says: “Overall, MRD negativity at a sensitivity of 10⁻⁶ was associated with a longer time to next treatment” https://t.co/TiRL44tvdc clonoSEQ® is FDA-cleared to assess MRD in MM, CLL and B-ALL. For further info: https://t.co/sE39cuZxFD https://t
RT @MichaelJSlade: I'm late to the party on this important paper by @Rfonsi1 looking at PET/clonoSeq MRD concordance at day +100 post-AHCT.…
RT @physorg_health: #Minimalresidualdisease #negativity predicts time to next treatment in multiple myeloma @BloodCancerJnl https://t.co/wn…